Jim A. Wright

发表

NC381, a Novel Anticancer Agent, Arrests the Cell Cycle in G0-G1 and Inhibits Lung Tumor Cell Growth in Vitro and in Vivo

M. Cao, Y. Lee, Ningping Feng, 2004, Journal of Pharmacology and Experimental Therapeutics.

A NOVEL ANTICANCER AGENT , ARRESTS THE CELL CYCLE IN G 0G 1 AND INHIBITS LUNG TUMOR CELL GROWTH IN VITRO AND IN VIVO

M. Cao, Y. Lee, Ningping Feng, 2003 .

Characterization of GPI2A, a Potent Inhibitor of HIV-1 Gene Expression and Viral Replication

M. Wainberg, H. Salomón, Jim A. Wright, 1997 .

Virulizin, a novel immunotherapy agent, stimulates TNFalpha expression in monocytes/macrophages in vitro and in vivo.

S. Der, M. Cao, Ningping Feng, 2007, International immunopharmacology.

GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors.

V. Lam, Y. Lee, Ningping Feng, 2003, Cancer research.

Development and Reliability of a System to Classify Gross Motor Function in Children with Cerebral Palsy

Sattar Alshryda, Jim A. Wright, S. Alshryda, 2014 .

The Hip in Myelomeningocele

Jason J. Howard, Jim A. Wright, E. Morakis, 2019, The Pediatric and Adolescent Hip.

Fibroblasts transformed by combinations of ras, myc and mutant p53 exhibit increased phosphorylation of histone H1 that is independent of metastatic potential

C. Allis, J. Davie, W. Taylor, 1995, FEBS letters.

Secreted phosphoprotein mrna is induced during multi‐stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts

A. Craig, A. Chambers, G. T. Bowden, 1990, International journal of cancer.

Anti-proliferative and anti-tumor effects of antisense oligonucleotide GTI-2601 targeted against human thioredoxin

Y. Lee, Ningping Feng, S. Viau, 2006, Anti-cancer drugs.

Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages

S. Der, M. Cao, Ningping Feng, 2005, Cancer Immunology, Immunotherapy.

Journal of Clinical Laboratory Analysis 19:182–188 (2005) Optimization of the PAXgene TM Blood RNA Extraction System for Gene Expression Analysis of Clinical Samples

Y. Lee, A. Vassilakos, Jim A. Wright, 2022 .

Characterization of LSI 78 Y Murine Lymphoblasts Resistant to Quinone Antitumor Agents 1

G. Goldenberg, Jim A. Wright, Marsha, 2006 .

Hydroxyurea-resistant mouse L cells with elevated levels of drug-resistant ribonucleotide reductase activity

Jim A. Wright, B. Kuzik, 1980, Biochemical Genetics.

FISH on purified extrachromosomal DNA molecules

S. Mai, J. Mushinski, Jim A. Wright, 1999 .

Antitumor activity of Virulizin, a novel biological response modifier (BRM) in a panel of human pancreatic cancer and melanoma xenografts

Ningping Feng, Hongnan Jin, M. Wang, 2003, Cancer Chemotherapy and Pharmacology.

IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo

M. Cao, Ningping Feng, X. Gu, 2010, Cancer Immunology, Immunotherapy.

Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors

S. Der, M. Cao, Ningping Feng, 2008, Cancer Immunology, Immunotherapy.

NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin

M. Cao, Ningping Feng, X. Gu, 2005, Cancer Immunology, Immunotherapy.

Triaryl methane derivatives as antiproliferative agents.

M. Cao, Raed A. Al‐Qawasmeh, A. Vassilakos, 2004, Bioorganic & medicinal chemistry letters.

Cellular signaling pathways affect the function of ribonucleotide reductase mRNA binding proteins: mRNA stabilization, drug resistance, and malignancy (Review).

Jim A. Wright, T. Burton, T. Kashour, 2003, International journal of oncology.

Bone Cysts Involving the Hip

Jim A. Wright, S. Alshryda, L. Deriu, 2019, The Pediatric and Adolescent Hip.

GTI-2040 displays cooperative anti-tumor activity when combined with interferon alpha against human renal carcinoma xenografts.

Y. Lee, Ningping Feng, S. Viau, 2009, International journal of oncology.

Preclinical efficacy of Virulizin in human breast, ovarian and prostate tumor models

Ningping Feng, Hongnan Jin, M. Wang, 2003, Anti-cancer drugs.

A link between ferritin gene expression and ribonucleotide reductase R2 protein, as demonstrated by retroviral vector mediated stable expression

Jim A. Wright, H. Fan, C. Villegas, 1996, FEBS letters.

GTI-2501, an antisense agent targeting R1, the large subunit of human ribonucleotide reductase, shows potent anti-tumor activity against a variety of tumors.

Y. Lee, Ningping Feng, M. Wang, 2006, International journal of oncology.

Membrane glycoprotein changes during the senescence of normal human diploid fibroblasts in culture

J. Dick, J. Blondal, Jim A. Wright, 1985, Mechanisms of Ageing and Development.

Natural Killer Cell Regulation of Implantation and Early Lung Growth of Hras-transformed lOTVi Fibroblasts in Mice 1

Jim A. Wright, S. Egan, A. Greenberg, 2006 .

Ribonucleotide reductase activity during the senescence of normal human diploid fibroblasts in culture

J. Dick, Jim A. Wright, 1985, Mechanisms of Ageing and Development.

Preclinical toxicity and toxicokinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase R2

Y. Lee, A. Vassilakos, Jim A. Wright, 2011, Cancer Chemotherapy and Pharmacology.

Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus.

Y. Lee, Raed A. Al‐Qawasmeh, Jim A. Wright, 2010, Bioorganic & medicinal chemistry letters.

11-Phenyl-[b,e]-dibenzazepine compounds: novel antitumor agents.

M. Cao, Raed A. Al‐Qawasmeh, S. Viau, 2009, Bioorganic & medicinal chemistry letters.

Human diploid fibroblasts with alterations in ribonucleotide reductase activity, deoxyribonucleotide pools and in vitro lifespan

J. Dick, Jim A. Wright, 1984, Mechanisms of Ageing and Development.

Lack of correlation between deoxyribonucleotide pool sizes, spontaneous mutation rates and malignant potential in Chinese hamster ovary cells

J. Damen, Jim A. Wright, A. Greenberg, 2004, Journal of Cancer Research and Clinical Oncology.

Involvement of ribonucleotide reductase activity in the senescence of normal human diploid fibroblasts

J. Dick, Jim A. Wright, 1982, Mechanisms of Ageing and Development.

Allosteric regulation of the activity of citrate snythetase of Escherichia coli by alpha-ketoglutarate.

Jim A. Wright, B. Sanwal, P. Maeba, 1967, Biochemical and biophysical research communications.

Characterization of deoxyguanosine-resistant hypoxanthine-guanine phosphoribosyltransferase− metastatic variants altered in soybean-agglutinin-binding properties and cell-surface glycoproteins

J. Damen, Jim A. Wright, A. Greenberg, 2005, Journal of Cancer Research and Clinical Oncology.

INVITATIONAL PAPER: SOMATIC CELL GENETICS: A REVIEW OF DRUG RESISTANCE, LECTIN RESISTANCE AND GENE TRANSFER IN MAMMALIAN CELLS IN CULTURE

Jim A. Wright, C. Parfett, W. H. Lewis, 1980 .

Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H‐ras transformed cell lines

Jim A. Wright, R. Hurta, 1994, Journal of cellular physiology.

RNA interference targeting the R2 subunit of ribonucleotide reductase inhibits growth of tumor cells in vitro and in vivo

Y. Lee, Ningping Feng, M. Wang, 2007, Anti-cancer drugs.

Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90

Jie Ge, James R. Porter, J. Sydor, 2006, Proceedings of the National Academy of Sciences.

c-Myc-induced extrachromosomal elements carry active chromatin.

S. Mai, Jim A. Wright, S. Symons, 2003, Neoplasia.

Relationship between reversion of hydroxyurea resistance in hamster cells and the co-amplification of ribonucleotide reductase M2 component, ornithine decarboxylase and P58 genes

Jim A. Wright, P. R. Srinivasan, G. McClarty, 1988 .

Increased Ser-10 Phosphorylation of Histone H3 in Mitogen-stimulated and Oncogene-transformed Mouse Fibroblasts*

C. Allis, J. Davie, D. Bazett-Jones, 1999, The Journal of Biological Chemistry.

Histone modifications, gene expression, and the nuclear matrix

C. Allis, J. Davie, Jim A. Wright, 1999 .

Drug Resistance and Gene Amplification Potential Regulated by Transforming Growth Factor ÃŸj

Aiping, Jim A. Wright, Huang, 2006 .

Drug Resistance and Gene Amplification Potential Regulated by Transforming Growth Factor β1 Gene Expression

Jim A. Wright, A. Huang, H. Jin, 1995 .

Aberrant TGF-β Production and Regulation in Metastatic Malignancy

M. Sporn, M. Gingras, P. Kondaiah, 1990 .

Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.

M. Cao, Y. Lee, Ningping Feng, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials

G. Pond, Jim A. Wright, T. Tsakiridis, 2017, Oncotarget.

A novel small molecule with potent anticancer activity inhibits cell growth by modulating intracellular labile zinc homeostasis

Y. Lee, Raed A. Al‐Qawasmeh, S. Viau, 2009, Molecular Cancer Therapeutics.

Classification of Hip Joint Dysplasia by Means of Sonography

Jim A. Wright, S. Alshryda, 2014 .

Surgical Dislocation of the Adult Hip: A Technique with Full Access to the Femoral Head and Acetabulum Without the Risk of Avascular Necrosis

Jim A. Wright, S. Alshryda, 2014 .

Characterization of SB-705498, a Potent and Selective Vanilloid Receptor-1 (VR1/TRPV1) Antagonist That Inhibits the Capsaicin-, Acid-, and Heat-Mediated Activation of the Receptor

Jim A. Wright, A. Randall, M. Gunthorpe, 2007, Journal of Pharmacology and Experimental Therapeutics.

Macrophages play a critical role in the anti-tumor activity of Virulizin.

Ningping Feng, M. Wang, Jim A. Wright, 2003, International journal of oncology.

Evidence of a common site of action for the antitumor agents, hydroxyurea and guanazole

Jim A. Wright, J. Wright, W. H. Lewis, 1974, Journal of cellular physiology.